The Epidural Era
Epidural analgesia became the standard for thoracotomy pain control because it worked. Continuous infusion of local anesthetic and opioid into the epidural space provided reliable analgesia for the acute postoperative period, and for operations involving rib spreading and intercostal nerve trauma, the alternative — systemic opioids alone — was inadequate. The epidural was invasive, required anesthesia or regional team placement, and carried risks including hypotension, urinary retention necessitating bladder catheterization, and motor blockade that delayed mobilization. But these were acceptable trade-offs for effective pain control in an operation known for severe postoperative pain.
The limitation was duration. Epidurals usually only give pain relief for a few days 1:57. Catheters were removed early in the hospital course, and patients transitioned to oral or intravenous opioids for the remainder of their recovery. The pain from intercostal nerve injury, however, persisted well beyond epidural removal, often for weeks. The mismatch between the duration of the injury and the duration of regional analgesia meant that the latter half of recovery relied heavily on narcotics.
What Drove the Shift
The recognition that intercostal nerve cryoablation — already in use for pectus excavatum repair — could provide analgesia lasting 4 to 6 weeks changed the calculation 1:25. The mechanism is axonal degeneration with preservation of the epineurium, allowing nerve regeneration without neuroma formation 1:19. Applied at the time of thoracotomy, cryoanalgesia could cover the entire recovery period rather than just the first few days 1:57.
One center's experience with 300 thoracotomy cases using cryoanalgesia demonstrated the practical advantages 2:10. The technique eliminated the need for epidural catheter placement, which in turn eliminated the Foley catheter required to manage epidural-related urinary retention 3:09. Patients mobilized immediately postoperatively 3:09. Pulmonary toilet improved 3:13. The comparison data were striking: in a study of 23 thoracotomies with cryoanalgesia, patients used 137 oral morphine equivalents during hospitalization compared to 533 in the regional nerve block group 3:50 — a nearly fourfold reduction 3:15. Patients were discharged without narcotic prescriptions 3:21.
The technical execution is straightforward. The cryoprobe is applied under direct visualization during the thoracotomy, 1 to 2 levels above and below the incision 2:17. Sixty seconds of freeze time is sufficient 2:32. Temporary intercostal nerve blocks bridge the first 8 hours before cryoanalgesia takes effect 2:33. The standard probe is used down to age 3, with cases performed in children as young as 18 months 2:39. Below that age, a cardiac probe is used 2:44. In smaller children, retractors hold skin away from the probe to prevent skin freeze, though newer probes with shaft insulation that remains at room temperature have eliminated this risk 2:52.
Current Practice
At the center with the largest reported experience, cryoanalgesia is now used for all thoracotomies except neonatal cases 3:50. The epidural is no longer the default. The shift reflects not just equivalent analgesia but operational advantages: no need to coordinate with a regional anesthesia team, no catheter-related complications, and earlier mobilization.
Yet adoption remains limited. Poll results from a combined live and virtual audience at a pediatric surgery update course showed that very few surgeons use intercostal nerve cryoablation for thoracotomy pain control 1:39. The gap between the published experience and widespread practice is large.
What Remains Unsettled
The anatomic boundaries are not fully defined. Cryoablation at T10 or lower risks pseudohernias from motor branch involvement 2:23, but the exact level at which this becomes prohibitive, and whether it varies by patient size or muscular development, is not established. The lower limit for patient age is empiric — 18 months with a standard probe, younger with a cardiac probe — but no systematic data define the safety threshold in infants.
The comparison study used a historical control of regional nerve blocks, not epidurals 3:29. Whether cryoanalgesia is superior to a well-managed epidural, or simply non-inferior with operational advantages, is not resolved. The study did not report pain scores, only opioid consumption, which is a proxy but not a direct measure of analgesia quality.
Finally, the neonatal thoracotomy remains an exception 3:50. Whether this reflects anatomic constraints, concerns about nerve regeneration in developing neural tissue, or simply lack of experience is unclear. If cryoanalgesia is safe and effective in 18-month-olds, the rationale for excluding neonates is not obvious and deserves examination.
Takeaways from this story
- Cryoanalgesia reduces opioid use fourfold vs regional blocks: 137 vs 533 morphine equivalents in 23 thoracotomy patients.
- Pain coverage lasts 4-6 weeks through axonal degeneration with intact epineurium, vs epidurals lasting only days.
- Apply probe 1-2 levels above/below incision for 60 seconds; avoid T10 or lower to prevent abdominal pseudohernias.
- Standard probe works to age 3 (youngest case 18 months); cardiac probe for smaller children with retractors to prevent skin freeze.